Life Sciences & Pharmaceutical Sector (International & Cross-Border) - USA
What the team is known for
Latham & Watkins is recognised as an excellent option for clients that require counsel on highly complex and multifaceted cross-border matters. The firm provides an impressive, well-integrated team across its global offices and is praised for consistently excelling across multiple practice areas and sectors, while delivering an internationally oriented approach and comprehensive global support. The firm's efficient coordination across its international network is key to its appeal among high-profile multinational corporations, banks and investment funds.
With impressive cross-practice strength, Latham & Watkins is typically instructed on large transactional matters relating to the life sciences sector. The firm acts for numerous global pharmaceutical and biotechnology companies, assisting with IP and commercial agreements as part of large global mergers in the industry. The firm's strong client base among private equity funds also ensures it has the experience to handle all manner of investments and buyouts in the industry.
Strengths
"Latham & Watkins is strong in understanding issues which have cross-border elements. "
"The lawyers do cross-border work for us and are great in handling such matters and connect us with experts in different places."
"One of the great advantages of instructing Latham is the depth and breadth of their team."
Notable practitioners
Peter Handrinos is noted for his representation of investment banks and public companies in life sciences-related capital markets transactions and securities-related matters. "Peter gives excellent business advice and is a strategic thinker who always considers the big picture."
Cheston Larson advises biotech and other life sciences companies through all stages of their life cycle. His practice focuses on corporate and financing transactions. His work covers venture financing, IPOs, and M&A transactions.
John Manthei advises pharmaceuticals, biotechnology and medical device companies on all manner of FDA and other regulatory procedures governing the life sciences sector. His expertise includes the negotiation of clinical trial agreements, pre-market product development and the regulation of marketing materials."
Michael Morin is known for his extensive representations of large pharmaceutical companies in connection to patent and copyright infringement matters. "Michael has done remarkable work for us."
